Lloyd Johnston
Equibles does not estimate personal net worth.
About Lloyd Johnston
Earlier roles on record: COO at Cartesian Therapeutics, Inc. (RNAC) until November 13, 2023. Cartesian Therapeutics, Inc. reported in an 8-K filed November 13, 2023 that Lloyd Johnston resigned as Chief Operations Officer, effective November 13, 2023. The proxy statement of Cartesian Therapeutics, Inc. reports total compensation of $2,697,590 for Lloyd Johnston in fiscal 2023, including a base salary of $431,336. Disclosed compensation is on record for 4 fiscal years.
“In accordance with the Merger Agreement, on November 13, 2023, immediately prior to the effective time of the First Merger ("Effective Time"), each of Peter Traber, Kei Kishimoto and Lloyd Johnston resigned as Chief Medical Officer, Chief Scientific Officer and Chief Operations Officer, respectively, following which Drs. Traber, Kishimoto, and Johnston will serve as Senior Clinical Advisor, Senior Scientific Advisor, and Senior Operations Advisor, respectively, to the Company.”
Affiliation history
-
Cartesian Therapeutics, Inc. (RNAC)
Proxy statement
Start not stated–2023-04-28
Last confirmed by a filing; no departure on record
-
Start not stated–2023-11-13
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Cartesian Therapeutics, Inc. (RNAC) | Former Chief Operations Officer | $431,336 | $2,697,590 |
| 2022 | Cartesian Therapeutics, Inc. (RNAC) | Former Chief Operations Officer | $413,169 | $1,674,359 |
| 2021 | Cartesian Therapeutics, Inc. (RNAC) | Chief Operations Officer | $399,764 | $1,304,845 |
| 2020 | Cartesian Therapeutics, Inc. (RNAC) | Chief Operations Officer | $384,537 | $889,306 |